Bioinfosol Spain
Research
Date range: 1 March 2021 - 28 February 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Bioinfosol published between 1 March 2021 - 28 February 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
1 | 0.00 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 1 | 0.00 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Collaboration
Date range: 1 March 2021 - 28 February 2022
International vs. domestic collaboration by Share
- 0.54% Domestic
- 99.46% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Bioinfosol by Share (3 total)
-
Bioinfosol and Centre for Genomics and Oncological Research (GENYO)
(0.00)
-
Bioinfosol and Regional Government of Andalusia
(0.00)
-
Bioinfosol and University of Granada (UGR)
(0.00)
Top 10 international collaborators with Bioinfosol by Share (233 total)
-
Bioinfosol and Leiden University
(0.05)
-
Bioinfosol and University of Groningen (RUG)
(0.04)
-
Bioinfosol and Harvard University
(0.03)
-
Bioinfosol and University of Oxford
(0.03)
-
Bioinfosol and The University of Edinburgh
(0.03)
-
Bioinfosol and The University of North Carolina at Chapel Hill (UNC)
(0.03)
-
Bioinfosol and University of Michigan (U-M)
(0.03)
-
Bioinfosol and Lundquist Institute for Biomedical Innovation
(0.03)
-
Bioinfosol and University of Copenhagen (UCPH)
(0.03)
-
Bioinfosol and Wellcome Trust - MRC Institute of Metabolic Science (IMS)
(0.02)

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.